Jan H. Niess

Basel, BS 4031, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.

Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.

Journal: Science translational medicine
Published: July 22, 2026

Pathways of Epithelial Barrier Breakdown and Remodeling in Esophageal Organoids by Commonly Used Surfactants.

Pathways of Epithelial Barrier Breakdown and Remodeling in Esophageal Organoids by Commonly Used Surfactants.

Journal: Allergy
Published: April 02, 2026

Potential approaches in repairing the damaged epithelial barrier in eosinophilic esophagitis.

Potential approaches in repairing the damaged epithelial barrier in eosinophilic esophagitis.

Journal: Expert review of clinical immunology
Published: March 08, 2026

Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis.

Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis.

Journal: United European gastroenterology journal
Published: December 04, 2025

Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease.

Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease.

Journal: Gut microbes
Published: July 21, 2025

Cytochrome P450 Cyp2s1 regulation of the intestinal metabolome and microbiome.

Cytochrome P450 Cyp2s1 regulation of the intestinal metabolome and microbiome.

Journal: Mucosal immunology
Published: July 16, 2025

Genetic deletion of the inflammatory bowel disease-associated risk gene Rgs14 aggravates experimental colitis.

Genetic deletion of the inflammatory bowel disease-associated risk gene Rgs14 aggravates experimental colitis.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 24, 2025

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

Journal: Vaccines
Published: May 24, 2025

Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study.

Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study.

Journal: Alimentary pharmacology & therapeutics
Published: March 12, 2025

Fatigue Is Strongly Associated with Depressive Symptoms in Patients with Inflammatory Bowel Disease.

Fatigue Is Strongly Associated with Depressive Symptoms in Patients with Inflammatory Bowel Disease.

Journal: Inflammatory intestinal diseases
Published: November 04, 2024

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

Journal: Vaccines
Published: October 02, 2024

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics
Published: August 28, 2024
Showing 1-12 of 63

Last Updated: 09/26/2026